Johnson & Johnson's commitment to innovative health care products has resulted in consistent financial performance. The Company has 29 consecutive years of adjusted earnings increases and 51 consecutive years of dividend increases.

Johnson & Johnson, through its family of companies, employs approximately 128,000 people worldwide and is engaged in the manufacture and sale of a broad range of products in the health care field in many countries of the world. Johnson & Johnson's primary interest, both historically and currently, has been in products related to health and well-being. Johnson & Johnson was organized in the State of New Jersey in 1886.

Johnson & Johnson is organized on the principles of decentralized management. The Executive Committee of Johnson & Johnson is the principal management group responsible for the strategic operations and allocation of resources of the Johnson & Johnson family of companies. Johnson & Johnson's operating companies are organized into three business segments: Consumer, Pharmaceutical and Medical Devices and Diagnostics. A Group Operating Committee, composed of managers who represent key operations within the segment, as well as management in specialized functional departments, oversees and coordinates the activities of domestic and international companies related to each of the business segments. However, in line with the principle of decentralized management, senior management groups at U.S. and international operating companies are each responsible for their own strategic plans, as well as the day-to-day operations of those companies, and each international company is, with some exceptions, managed by citizens of the country where it is located.

Our Company
Our Caring
Our Products
Our Credo Values
Our History

Shareholder Information Exchange
New York Stock Exchange
Stock Quote (JNJ)
$86.36  $0.73
Minimum 20 minutes delayed

Listed Security
JNJ  Common Stock

Transfer Agent
Computershare

Independent Accountants
PriceWaterhouseCoopers LLP